scholarly article | Q13442814 |
P50 | author | Janne Backman | Q51368670 |
Xiaoqiang Xiang | Q91330674 | ||
Pertti J. Neuvonen | Q23039874 | ||
Mikko Niemi | Q42328966 | ||
P2860 | cites work | Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events | Q45262208 |
Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans. | Q46040113 | ||
Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate | Q46365149 | ||
CYP7A1 promoter polymorphism -203A>C affects bile salt synthesis rate in patients after ileal resection | Q46410501 | ||
Genetic polymorphism in cytochrome P450 7A1 and risk of colorectal cancer: the Fukuoka Colorectal Cancer Study | Q46417602 | ||
A promoter polymorphism in cholesterol 7alpha-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin | Q46504831 | ||
Sex differences in the size of bile acid pools | Q47317121 | ||
Novel LC-MS/MS method for assay of 7alpha-hydroxy-4-cholesten-3-one in human plasma. Evidence for a significant extrahepatic metabolism. | Q51469738 | ||
Genetic polymorphism of cholesterol 7alpha-hydroxylase (CYP7A1) and colorectal adenomas: Self Defense Forces Health Study. | Q53347067 | ||
No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid | Q57825120 | ||
Mechanism-Based Inactivation of CYP2C8 by Gemfibrozil Occurs Rapidly in Humans | Q57825125 | ||
Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren | Q57825127 | ||
Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene | Q33243916 | ||
Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients | Q33997826 | ||
Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake | Q34626398 | ||
Polymorphisms at cholesterol 7alpha-hydroxylase, apolipoproteins B and E and low density lipoprotein receptor genes in patients with gallbladder stone disease | Q36308140 | ||
Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate | Q36338007 | ||
Review article: The function and regulation of proteins involved in bile salt biosynthesis and transport | Q37032752 | ||
Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential | Q37184737 | ||
Fifty years of advances in bile acid synthesis and metabolism | Q37278814 | ||
Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations | Q37379392 | ||
Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentration | Q40382532 | ||
Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren | Q42954978 | ||
Gemfibrozil markedly increases the plasma concentrations of montelukast: a previously unrecognized role for CYP2C8 in the metabolism of montelukast | Q42997336 | ||
Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren | Q43055993 | ||
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren | Q43152152 | ||
Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort | Q43209469 | ||
High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma | Q43234078 | ||
Variable association between genetic variation in the CYP7 gene promoter and plasma lipoproteins in three Canadian populations | Q43546745 | ||
Effects of treatment with deoxycholic acid and chenodeoxycholic acid on the hepatic synthesis of cholesterol and bile acids in healthy subjects | Q43601201 | ||
Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study | Q44480278 | ||
Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals | Q44969268 | ||
P433 | issue | 3 | |
P304 | page(s) | 245-252 | |
P577 | publication date | 2011-10-07 | |
P1433 | published in | Basic and Clinical Pharmacology and Toxicology | Q15724438 |
P1476 | title | Gender, but not CYP7A1 or SLCO1B1 polymorphism, affects the fasting plasma concentrations of bile acids in human beings. | |
P478 | volume | 110 |
Q35993511 | Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults--Results from the Cross-Sectional KarMeN Study |
Q35476085 | CYP7A1 gene polymorphism located in the 5' upstream region modifies the risk of coronary artery disease |
Q36414100 | Determinants of post-prandial plasma bile acid kinetics in human volunteers |
Q99604573 | Identification of Glycochenodeoxycholate 3-O-Glucuronide and Glycodeoxycholate 3-O-Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers |
Q36972804 | Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury. |
Search more.